Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial assessing the safety and dosing of the combination of bortezomib and gemcitabine in older patients with advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial update on using combination chemotherapy and total-body irradiation before donor umbilical cord blood transplant in patien…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer [Phase 2]
Phase 2 trial of gemcitabine with or without imatinib mesylate in previously treated metastatic breast cancer was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Clinical Trial of Trametes Versicolor in Women With Breast Cancer [Phase 1]
This is a Phase 1 clinical trial evaluating Trametes Versicolor in women with breast cancer. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating biological therapies following peripheral stem cell transplantation in patients with non-Hodgkin lymphoma,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: A Dose-escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of GDC-0032 in Combination With Docetaxel or With Paclitaxel in Patients With HER2-negative Locally Recurrent or Metastatic Breast Cancer or Non-small Cell Lung Cancer [Phase 1]
Phase 1 dose-escalation study evaluating safety, tolerability, and pharmacokinetics of GDC-0032 (taselisib) in combination with docetaxel or…
-
CLINICAL_TRIALS trial_result · 2017-11-28Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improv…
-
CLINICAL_TRIALS trial_result · 2017-11-27Clinical Trial Update: Enhancing Hope Among Patients With Poor-Prognosis Breast Cancer and Oncologists [NA]
This is a clinical trial update describing a study intended to improve hope among patients with poor-prognosis breast cancer and their oncol…
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia [Phase 2]
Phase IIa trial results assess the efficacy and safety of Myelo001 for chemotherapy-induced neutropenia with completed status.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
A completed study evaluating the cognitive and functional effects of chemotherapy in women with newly diagnosed early-stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-11-24Clinical Trial Update: S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer [NA]
A completed clinical trial evaluating high-dose cholecalciferol (vitamin D3) for prevention in premenopausal women at high risk for breast c…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Effectiveness of Tailored Rehabilitation Education on Health Literacy and Health Status of Postoperative Patients With Breast Cancer: a Randomized Controlled Trial [NA]
This completed randomized controlled trial evaluated whether tailored rehabilitation education improves health literacy and health status in…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients [NA]
A completed clinical trial evaluating decision role concordance in newly diagnosed breast cancer patients, sponsored by the University of Ut…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors [Phase 1]
This clinical trial update reports Phase 1 results on veliparib, evaluating safety, pharmacokinetics, and oral bioavailability in subjects w…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy [NA]
Clinical trial update on using breast vascular contrast-enhanced ultrasound (VCEUS) to evaluate early response to neoadjuvant chemotherapy i…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer [Phase 3]
Phase 3 trial evaluating clodronate with or without chemotherapy and/or hormonal therapy in women with early-stage breast cancer has complet…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors [Phase 1]
This Phase 1 study evaluated the effects of Veliparib on heart rhythms in patients with solid tumors.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Phase 2 Study of Adjuvant Radiotherapy in Breast Cancer Using a Once a Week Hypofractionated Regimen [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating a once-a-week hypofractionated adjuvant radiotherapy regimen…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB) [Phase 1]
Phase 1 trial updates report three combination arms: pazopanib with paclitaxel, pazopanib with paclitaxel plus carboplatin, and pazopanib wi…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer [Phase 1]
A Phase 1 study evaluating the effect of lapatinib on the pharmacokinetics of digoxin in subjects with ErbB2/HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Rollover Study Of Lapatinib In Cancer Patients [Phase 1]
Phase 1 rollover study of lapatinib in cancer patients, including breast cancer, has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy [Phase 1]
Phase 1 trial evaluating Fosaprepitant dimeglumine with a Granisetron transdermal system to prevent chemotherapy-induced nausea and vomiting…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Feasibility Study of Cavitary Radiofrequency Ablation in Excised Mastectomy Breast Tissue
The completed feasibility trial assessed whether cavitary radiofrequency ablation can be feasibly applied to excised breast tissue from prop…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer [Phase 3]
This Phase 3 trial comparing neoadjuvant chemo-endocrine therapy to chemotherapy alone in ER-positive, HER2-negative breast cancer has compl…